weight loss drug news today glp-1 october 2025 Americans turn to risky unregulated sellers for weight-loss drugs GLP-1 Pipeline Update: August 2025
Description
Ziyad Al-Aly, who is chief of research and development at the VA St
Graaf C, Donnelly D, Wootten D, et al
Weight loss and metabolic improvement may contribute to cognitive benefits
Liraglutide, a oncedaily human GLP1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD1 SU)
Some studies have shown that if we are overweight, obese, or have type 2 diabetes, our GLP-1 levels may be lower
